Showing results (701-710 of 974) with videos related to
Sort By:
Pageof 98
Journal of Anxiety Disorders|August 28, 2009
Anxiety and depressive disorders in offspring at high risk for anxiety: a meta-analysisJamie A Micco, Aude Henin, Eric Mick, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|January 30, 2007
Omega-3 fatty acid monotherapy for pediatric bipolar disorder: a prospective open-label trialJanet Wozniak, Joseph Biederman, Eric Mick, et al.CNS Spectrums|September 7, 2007
An open-label trial of aripiprazole monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Eric Mick, Thomas Spencer, et al.Contemporary Clinical Trials Communications|October 14, 2022
Studying the implementation of Zero Suicide in a large health system: Challenges, adaptations, and lessons learnedEdwin D Boudreaux, Celine Larkin, Ana Vallejo Sefair, et al.Schizophrenia Bulletin|December 1, 2012
Performance on the Wisconsin Card Sorting Test in families of schizophrenia patients with different familial loadingsSheng-Hsiang Lin, Chih-Min Liu, Tzung-Jeng Hwang, et al.Journal of Child Psychology and Psychiatry, and Allied Disciplines|January 13, 2015
White matter microstructure and developmental improvement of hyperactive/impulsive symptoms in attention-deficit/hyperactivity disorderWinke Francx, Marcel P Zwiers, Maarten Mennes, et al.CNS Neuroscience & Therapeutics|April 27, 2010
A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorderJoseph Biederman, Gagan Joshi, Eric Mick, et al.Psychiatry Research|November 14, 2012
Atomoxetine increases fronto-parietal functional MRI activation in attention-deficit/hyperactivity disorder: a pilot studyGeorge Bush, Jennifer Holmes, Lisa M Shin, et al.European Child & Adolescent Psychiatry|October 29, 2015
The influence of comorbid oppositional defiant disorder on white matter microstructure in attention-deficit/hyperactivity disorderHanneke van Ewijk, Siri D S Noordermeer, Dirk J Heslenfeld, et al.Psychological Medicine|September 19, 2018
Trajectories of psychiatric diagnoses and medication usage in youth with 22q11.2 deletion syndrome: a 9-year longitudinal studyWendy R Kates, Margaret A Mariano, Kevin M Antshel, et al.Pageof 98